Master One Thing - Rapamycin Longevity Series
Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
Oct 17, 2023
Leading researcher Brian Kennedy discusses his extensive longevity research experience, his involvement in longevity companies, and his current longevity research project in Singapore. Topics include early discoveries in longevity research, the significance of the TORE pathway in nutrient signaling and longevity, the efficacy of NAD precursors, plans for the Rapa Mysen trial, exploring rapamycin derivatives, and the debate surrounding high protein vs low protein intake.
01:11:04
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Promising longevity interventions include rapamycin, AKG, and rejuvenation studies with senescent cell clearance showing great potential.
- Personalized approaches to longevity interventions are crucial for better outcomes based on individual characteristics and genetic profiles.
Deep dives
Promising Longevity Interventions
Promising longevity interventions for humans include rapamycin, AKG, and rejuvenation studies. Rapamycin is considered a gold standard with proven efficacy. AKG supplementation has shown positive effects on health span and longevity in animal and human studies. Rejuvenation therapies, particularly for senescent cell clearance, show great potential for improving overall health and aging outcomes.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
